Market revenue in 2023 | USD 1,161.1 million |
Market revenue in 2030 | USD 1,605.4 million |
Growth rate | 4.7% (CAGR from 2023 to 2030) |
Largest segment | Cancer research |
Fastest growing segment | Cancer Research |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cancer Research |
Key market players worldwide | Thermo Fisher Scientific Inc, Eurofins Scientific SE, Qiagen NV, Wuxi AppTec Co Ltd, Promega, Abcam PLC, Merck KGaA, PerkinElmer, Enzo Biochem Inc, Becton Dickinson & Co |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to g-protein coupled receptors (gpcrs) market will help companies and investors design strategic landscapes.
Cancer research was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe g-protein coupled receptors (gpcrs) market based on cancer research covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe g-protein coupled receptors (gpcrs) market , including forecasts for subscribers. This continent databook contains high-level insights into Europe g-protein coupled receptors (gpcrs) market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account